Cargando…

Hidden Burden of Electronic Health Record‐Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care

BACKGROUND: Familial hypercholesterolemia (FH), is a historically underdiagnosed, undertreated, high‐risk condition that is associated with a high burden of cardiovascular morbidity and mortality. In this study, we use a population‐based approach using electronic health record (EHR)‐based algorithms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Prashant, Hu, Yirui, Kolinovsky, Amy, Geng, Zhi, Ruhl, Jeffrey, Krishnamurthy, Sarath, deRichemond, Caroline, Khan, Ayesha, Kirchner, H. Lester, Metpally, Raghu, Jones, Laney K., Sturm, Amy C., Carey, David, Snyder, Susan, Williams, Marc S., Mehra, Vishal C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662375/ https://www.ncbi.nlm.nih.gov/pubmed/31256702 http://dx.doi.org/10.1161/JAHA.118.011822

Ejemplares similares

Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol
por: Jones, Laney K., et al.
Publicado: (2022)

Barriers, facilitators, and solutions to familial hypercholesterolemia treatment
por: Jones, Laney K., et al.
Publicado: (2020)

Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis
por: Jones, Laney K., et al.
Publicado: (2021)

Patient experiences align with the familial hypercholesterolemia global call to action
por: Jones, Laney K., et al.
Publicado: (2022)

Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data Screening
por: Gidding, Samuel S., et al.
Publicado: (2023)

Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia
por: Agarwala, Anandita, et al.
Publicado: (2021)

Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2021)

Impact of a Population Genomic Screening Program on Health Behaviors Related to Familial Hypercholesterolemia Risk Reduction
por: Jones, Laney K., et al.
Publicado: (2022)

Applying implementation science to improve care for familial hypercholesterolemia
por: Jones, Laney K., et al.
Publicado: (2022)

Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review
por: Hendricks-Sturrup, Rachele M., et al.
Publicado: (2019)

Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study
por: Walters, Nicole L., et al.
Publicado: (2023)

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
por: Jones, Laney K., et al.
Publicado: (2021)

Translating guidelines into practice via implementation science: an update in lipidology
por: Jones, Laney K., et al.
Publicado: (2022)

Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach
por: Jones, Laney K., et al.
Publicado: (2023)

Large-scale exome datasets reveal a new class of adaptor-related protein complex 2 sigma subunit (AP2σ) mutations, located at the interface with the AP2 alpha subunit, that impair calcium-sensing receptor signalling
por: Gorvin, Caroline M, et al.
Publicado: (2018)

Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2023)

Cross genome phylogenetic analysis of human and Drosophila G protein-coupled receptors: application to functional annotation of orphan receptors
por: Metpally, Raghu Prasad Rao, et al.
Publicado: (2005)

Genome wide survey of G protein-coupled receptors in Tetraodon nigroviridis
por: Metpally, Raghu Prasad Rao, et al.
Publicado: (2005)

Familial Hypocalciuric Hypercalcemia Type 1 and Autosomal-Dominant Hypocalcemia Type 1: Prevalence in a Large Healthcare Population
por: Dershem, Ridge, et al.
Publicado: (2020)

Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis
por: Sturm, Amy C., et al.
Publicado: (2021)

Comparative proteome analysis of psychrophilic versus mesophilic bacterial species: Insights into the molecular basis of cold adaptation of proteins
por: Metpally, Raghu Prasad Rao, et al.
Publicado: (2009)

Matrix Gla protein polymorphism rs1800801 associates with recurrence of ischemic stroke
por: Hendrix, Philipp, et al.
Publicado: (2020)

Analytical Validation of Familial Hypercholesterolemia Biomarkers in Dried Blood Spots
por: Held, Patrice K., et al.
Publicado: (2022)

Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia
por: Peterson, Amy L., et al.
Publicado: (2021)

Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication
por: Campbell-Salome, Gemme, et al.
Publicado: (2022)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population
por: Miller, Jason E., et al.
Publicado: (2019)

Correction to: Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population
por: Miller, Jason E., et al.
Publicado: (2019)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Prevalence and Treatment of Familial Hypercholesterolemia and Severe Hypercholesterolemia in Older Adults in Ontario, Canada
por: Akioyamen, Leo E., et al.
Publicado: (2022)

Familial Hypercholesterolemia: The Lipids or the Genes?
por: Fahed, Akl C, et al.
Publicado: (2011)

Nuclear Transport Modulation Reduces Hypercholesterolemia, Atherosclerosis, and Fatty Liver
por: Liu, Yan, et al.
Publicado: (2013)

The Hidden Tragedy of Rivers: A Decade of Unintentional Fatal Drowning in Australia
por: Peden, Amy E., et al.
Publicado: (2016)

Sex Differences in Familial Hypercholesterolemia
por: Klevmoen, Marianne, et al.
Publicado: (2023)

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
por: Tandirerung, Fistra Janrio
Publicado: (2022)

Genetic basis of hypercholesterolemia in adults
por: Saadatagah, Seyedmohammad, et al.
Publicado: (2021)

Hypercholesterolemia and its correlates in Taiwanese elderly people.
por: Lin, C. C., et al.
Publicado: (1999)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qquv0osboj910nhud7q1h1emhn